Doc said "Only a sociopath can work in mass therapy".

Published Date: 02 Mar 2023

Many doctors have accused hospitals and large hospitals of opposing quality care and promoting violence. Others disagree.

Read Full News

Latest News

Is Flare Prophylaxis Always Needed When Starting Gout Drugs?

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

CMV Infection in Early Pregnancy Tied to Autism Risk in Kids

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Medicine Through Film: 10 Classics for Clinicians

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

Corticosteroids May Raise Risk for Mortality in IPF

The use of corticosteroids is linked to a higher risk for mortality in patients with acute exacerbations of idiopathic pulmonary fibrosis.

Mollicute Screening Improves Outcomes After Lung Transplant

Donor-recipient RNA assay significantly reduced the days to diagnosis of infection.

Hung Up on Hantavirus? How to Answer If Patients Are Asking

Recent outbreak on a Dutch cruise ship poses no risk to public at large, experts say.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Todays Updates

Only 1 in 4 Eligible Adults Receive Lung Screening

Complicated eligibility rules, stigma surrounding smoking and lung cancer, and confusion about the screening process continue to keep many high-risk patients from getting screened.

Low PSA May Not Fully Predict Survival in Prostate Cancer

A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.

FDA Warns of Secondary Blood Cancer Risk With Tazverik

The FDA says the increased risk of hematologic secondary primary malignancies with tazemetostat now outweighs the benefits of the drug; Ipsen pulls it from the market.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

The BCL-2 inhibitor was granted accelerated approval based on findings from the phase 1/2 BGB-11417-201 study.

Latest News

There are divided opinions over whether anti-inflammatory drugs should always be used when initiating urate-lowering therapy for gout. Would a ‘pill in the pocket’ approach be better?

Children with congenital cytomegalovirus infection may experience complications such as autism and hearing loss if their mothers have a first-time infection during the first trimester.

Ten cinematic classics trace medicine’s moral, social, and scientific dilemmas — a curated watchlist that highlights storytelling, stigma, and a call for female leads.

The use of corticosteroids is linked to a higher risk for mortality in patients with acute exacerbations of idiopathic pulmonary fibrosis.

Donor-recipient RNA assay significantly reduced the days to diagnosis of infection.

Recent outbreak on a Dutch cruise ship poses no risk to public at large, experts say.

News All Time

Why Quality Health Information May Drive Health Outcomes

Widespread use of online medical content and AI tools is reshaping decision-making and raising concerns about misinformation.

Inosine Pranobex Linked to Lower Mortality Risk in COVID

The use of inosine pranobex is associated with a lower risk for mortality in patients with COVID, a new study suggests.

EMA Greenlights Drugs for MS and Spinal Muscular Atrophy

Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.

Bipolar II Disorder May Raise the Risk for Mortality

Bipolar II disorder is associated with higher all-cause mortality risk in teens and adults than bipolar disorder I or not having either condition, a new study shows.

Loneliness and Isolation: The Hidden Costs of Hospitalization

Adults who are hospitalized often feel lonely and socially isolated.

How Caring Differently Eases GP Stress Levels

GPs with a patient-centred orientation may experience lower perceived stress, whereas those with a higher number of daily patient contacts may experience higher stress.

UK Lawmakers Approve Lifetime Smoking Ban for Today's Under-18s

Children in Britain who are 17 or younger, and anyone born in the future, will never be able to ⁠legally buy cigarettes after lawmakers approved new stricter restrictions on...

COVID’s Cicada Invasion Doesn’t Yet Prompt Concerns

A previously dormant variant appears to evade the current vaccine, but impact remains unclear.

Crumbling NHS Hospitals to Face More Years of Risk and Cost

Seven hospitals with dangerous RAAC concrete won't be replaced until 2032-2033, costing up to £140 million extra per year of delay.

Fast-spreading Measles Outbreak Has Killed At Least 30 in Bangladesh, WHO Says

Bangladesh has confirmed 30 deaths in a measles outbreak that has spread ⁠rapidly across the country, with most of the victims aged under two, the World Health ⁠Organization...

Digital Twin Platform Comes to Orthopedics to Optimize Care

The platform will be used to build virtual anatomic replicas of patients to run simulations and plan surgery, make intraoperative decisions, and predict outcomes across treatment options.

NP-Led Clinic Boosts Care for Chronic Kidney Disease

A nurse practitioner-led clinic for chronic kidney disease improves clinical outcomes and increases the use of guideline-directed therapies and patient satisfaction, a study shows.

Recurring UTIs? Should Cranberry Products Be Recommended?

Evidence supports cranberry for the prevention, not treatment, of urinary tract infections, with standardized dosing critical to clinical benefit.

Analysis-COVID Shots, Newer Vaccines in Limbo After US Court Halts Kennedy’s Advisory Panel

Americans may face the next respiratory disease season without clear guidance for COVID shots and updated flu vaccines after a federal court ruling last month left several...

ACP Updates Guidance on Breast Cancer Screening

‘Sensible’ recommendations support biennial screening from age 50 to 74, with individualized decision-making for women below or above these age thresholds.

Hamilton Conservation Authority to Accept Nature Prescriptions

Hamilton Conservation Authority Joins PaRx, providing prescribers with a new strategy to improve health outcomes: nature.

Recommended News For You

According to JAMA, even four minutes a day of exercise can lower the risk of cancer.

New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

Kate Middleton Reaches Cancer Treatment Milestone

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

The Early Progression of Prostate Cancer Is Not Stopped by Metformin.

Recommended Articles For You

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec 

The Latest Research on Wiskott Aldrich Syndrome  

Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

2.

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

3.

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

4.

Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity

5.

Young adults who are obese are at risk for 17 different types of cancer in the future.

1.

The Latest Research on Wiskott Aldrich Syndrome 

2.

The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring

3.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

4.

Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer

5.

Introduction to Immune Thrombocytopenic Purpura

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II

2.

Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients

3.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

5.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot